Clinical TrialsSearch results
Number of results: 218
Other
- The efficacy and feasibility of the repeated intraperitoneal Paclitaxel +systemic TS-1 and Paclitaxel for far advanced or recurrent gastric cancer: Phase I/II trial.
- Far advanced or recurrent gastric cancer
- Department of Surgical Oncology The University of Tokyo
- 2008-08-30
Recruiting
- Prospective randomized Phase II trial in nutritional support for autologous PBSCT Non-synbiotics vs Synbiotics
- malignant lymphoma or multiple myeloma
- National Cancer Center Hospital
- 2008-08-29
Other
- Outcome study of complete resections for p-N2 non-small cell lung cancer
- non-small cell lung cancer
- JMTO
- 2008-07-28
Recruiting
- Phase II trial using imatinib combined with chemotherapy for newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ALL)
- Japan Adult Leukemia Study Group
- 2008-07-07
Other
- Secondary Prevention of Cerebral Infarction Epidemiological Study on Cerebral Microbleeds
- cerebral infaction
- SCIENCE Study Protocol Comittee
- 2008-07-02
Other
- A multi-center randomized phase II study of nutritonal support with intensive glucose control after allogeneic stem cell transplantation lipid-free vs lipid
- hematological malignancies
- National Cancer Center Hospital
- 2008-06-16
Other
- study of Helicobacter pylori Eradication after endoscopic resection of early gastric cancer
- early stage of gastric cancer
- Japan Gast Study Group
- 2008-05-31
Other
- Outcome Assessment using SF-36 v2 in Stroke Patient Study
- Brain infarction
- OASIS STUDY Research Group
- 2008-05-31
Other
- Randomized control trial on efficacy of transcatheter arterial chemoembolization with cisplatin-lipiodol suspension or epirubicin-lipiodol emulsion for hepatocellular carcinoma.
- Hepatocellular carcinoma
- Department of Gastroenterology and Hepatology, Okayama University Graguate School of Medicine, Dentistry and Pharmaceutical Sciences.
- 2008-05-20
Other
- Combination Therapy of Hypertension to Prevent Cardiovascular Events Trial
- Outpatients who are required a combination therapy with sitting systolic blood pressure >=140 mmHg or diastolic blood pressure>=90 mmHg
- COPE Trial Group
- 2008-05-12